stockportfolio.pro
CTAS vs EMR: Which Stock Is the Better Buy?
Cintas Corporation and Emerson Electric Co. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Industrials.
AI verdict — CTAS vs EMR, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Cintas Corporation (CTAS) | Emerson Electric Co. (EMR) | |
|---|---|---|
| Market cap | $72.6B | $77.9B |
| Revenue (latest FY) | $10.34B | $18.02B |
| Net income (latest FY) | $1.81B | $2.29B |
| Revenue growth (5y CAGR) | 7.9% | 1.4% |
| Net margin | 17.5% | 12.7% |
| Return on equity | 38.7% | 11.3% |
| P/E ratio | 38.3 | 32.2 |
| Dividend yield | 1.0% | 1.6% |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | Yes | Yes |
See the full CTAS vs EMR breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open CTAS's full financials → Open EMR's full financials →More comparisons
Frequently asked questions
Which is bigger, CTAS or EMR?
Emerson Electric Co. is larger by market capitalization — $77.9B versus $72.6B.
Which grows faster, CTAS or EMR?
Over the last five fiscal years, Cintas Corporation grew revenue faster — 7.9%/yr versus 1.4%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
CTAS fundamentals → · EMR fundamentals → · All 1,500+ companies → · Free screener →